Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate cancer screening Guidelines


Authors: Wei, J. T.; Barocas, D.; Carlsson, S.; Coakley, F.; Eggener, S.; Etzioni, R.; Fine, S. W.; Han, M.; Kim, S. K.; Kirkby, E.; Konety, B. R.; Miner, M.; Moses, K.; Nissenberg, M. G.; Pinto, P. A.; Salami, S. S.; Souter, L.; Thompson, I. M.; Lin, D. W.
Title: Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate cancer screening
Abstract: Purpose: The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer screening, biopsy, and follow-up. This is Part I of a two-part series that focuses on prostate cancer screening. Please refer to Part II for discussion of initial and repeat biopsies as well as biopsy technique. Materials and Methods: The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane Database of Systematic Reviews (January 1, 2000-November 21, 2022). Searches were supplemented by reviewing reference lists of relevant articles. Results: The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy technique. Conclusions: Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a basis for longer screening intervals and tailored screening, and the use of available online risk calculators is encouraged.
Keywords: mortality; biopsy; risk; prostate cancer; psa; imaging; radical prostatectomy; model; follow-up; mutations; men; strategies; shared decision-making; antigen levels; benefits; prostate cancer screening; risk calculator; early detection of prostate cancer; screening interval; dre
Journal Title: Journal of Urology
Volume: 210
Issue: 1
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 2023-07-01
Start Page: 46
End Page: 53
Language: English
ACCESSION: WOS:001144485200020
DOI: 10.1097/ju.0000000000003491
PROVIDER: wos
PUBMED: 37096582
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Samson W Fine
    457 Fine
  2. Sigrid Viktoria Carlsson
    220 Carlsson